Research progress on the association between pancreatic fatty infiltration and acute pancreatitis

doi:10.3877/cma.j.issn.2095-2015.2026.01.016

Abstract

Abstract:

Pancreatic fat infiltration, also known as pancreatic steatosis, is characterized by excessive lipid accumulation within the pancreas, which can lead to irreversible fat replacement of pancreatic cells. In severe cases, it can result in non-alcoholic fatty pancreas disease, associated with clinical manifestations such as β-cell dysfunction, type 2 diabetes, and acute pancreatitis. As a trigger and risk factor for various diseases, the diagnosis and management of pancreatic fat infiltration are crucial for early detection and intervention. This review focuses on the epidemiological characteristics of pancreatic fat infiltration and its relationship with acute pancreatitis, highlights the latest research progress, and explores relevant pathophysiological mechanisms, aiming to provide insights for clinical diagnosis and intervention.

Key words: Acute pancreatitis, Pancreatic fat infiltration, Risk factor

Manhui Yang, Ping Chen. Research progress on the association between pancreatic fatty infiltration and acute pancreatitis[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2026, 16(01): 91-96.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhxhbyyxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-2015.2026.01.016

https://zhxhbyyxzz.cma-cmc.com.cn/EN/Y2026/V16/I01/91

References 52

[1]	Pinte L, Balaban D V, Baicus C, et al. Non-alcoholic fatty pancreas disease-practices for clinicians[J]. Rom J Intern Med, 2019, 57(3): 209-219.
[2]	Schaefer J H. The normal weight of the pancreas in the adult human being: A biometric study[J]. The Anatomical Record, 1926, 32(2): 119-132.
[3]	Ogilvie RF. The islands of langerhans in 19 cases of obesity[J]. The Journal of Pathology and Bacteriology, 1933, 37: 473-481.
[4]	Petrov MS, Taylor R. Intra-pancreatic fat deposition: bringing hidden fat to the fore[J]. Nat Rev Gastroenterol Hepatol, 2022, 19(3): 153-168.
[5]	SILVA L, FERNANDES MSS, LIMA EA, et al. Fatty Pancreas: Disease or Finding?[J]. Clinics(Sao Paulo), 2021, 76: e2439.
[6]	Caldart F, De Pretis N, Luchini C, et al. Pancreatic steatosis and metabolic pancreatic disease: a new entity?[J]. Intern Emerg Med, 2023, 18(8): 2199-2208.
[7]	Habas E, Farfar K, Habas E, et al. Extended Review and Updates of Nonalcoholic Fatty Pancreas Disease[J]. Saudi J Med Med Sci, 2024, 12(4): 284-291.
[8]	Heni M, Machann J, Staiger H, et al. Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study[J]. Diabetes Metab Res Rev, 2010, 26(3): 200-205.
[9]	Yamazaki H, Tauchi S, Kimachi M, et al. Independent association between prediabetes and future pancreatic fat accumulation: a 5-year Japanese cohort study[J]. J Gastroenterol, 2018, 53(7): 873-882.
[10]	Ke P, Sc C, C L, et al. Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition[J]. Obesity Research, 2008, 16(3): 522-530.
[11]	Singh Rg, Yoon Hd, Wu LM, et al. Ectopic fat accumulation in the pancreas and its clinical relevance: A systematic review, meta-analysis, and meta-regression[J]. Metabolism, 2017, 69: 1-13.
[12]	Fujii M, Ohno Y, Yamada M, et al. Impact of fatty pancreas and lifestyle on the development of subclinical chronic pancreatitis in healthy people undergoing a medical checkup[J]. Environ Health Prev Med, 2019, 24(1): 10.
[13]	Kim HJ, Byun JH, Park SH, et al. Focal fatty replacement of the pancreas: usefulness of chemical shift MRI[J]. AJR Am J Roentgenol, 2007, 188(2): 429-432.
[14]	Hong CW, Fazeli Dehkordy S, Hooker JC, et al. Fat Quantification in the Abdomen[J]. Top Magn Reson Imaging, 2017, 26(6): 221-227.
[15]	Gaborit B, Abdesselam I, Kober F, et al. Ectopic fat storage in the pancreas using 1H-MRS: importance of diabetic status and modulation with bariatric surgery-induced weight loss[J]. Int J Obes(Lond), 2015, 39(3): 480-487.
[16]	Kim J, Albakheet SS, Han K, et al. Quantitative MRI Assessment of Pancreatic Steatosis Using Proton Density Fat Fraction in Pediatric Obesity[J]. Korean J Radiol, 2021, 22(11): 1886-1893.
[17]	Siddiqui N, Vendrami C L, Chatterjee A, et al. Advanced MR Imaging Techniques for Pancreas Imaging[J]. Magn Reson Imaging Clin N Am, 2018, 26(3): 323-344.
[18]	Sezgin O, Yaras S, Ozdogan O. Pancreatic Steatosis Is Associated with Both Metabolic Syndrome and Pancreatic Stiffness Detected by Ultrasound Elastography[J]. Dig Dis Sci, 2022, 67(1): 293-304.
[19]	Hirooka Y, Kuwahara T, Irisawa A, et al. JSUM ultrasound elastography practice guidelines: pancreas[J]. J Med Ultrason(2001), 2015, 42(2): 151-174.
[20]	Pang C, Dong P, Yang J, et al. Non-alcoholic fatty pancreas disease: an updated review[J]. J Pancreatol, 2024, 7(3): 212-221.
[21]	Marti-Aguado D, Ten-Esteve A, Baracaldo-Silva C M, et al. Pancreatic steatosis and iron overload increases cardiovascular risk in non-alcoholic fatty liver disease[J]. Front Endocrinol(Lausanne), 2023, 14: 1213441.
[22]	Dong X, Zhu Q, Yuan C, et al. Associations of Intrapancreatic Fat Deposition With Incident Diseases of the Exocrine and Endocrine Pancreas: A UK Biobank Prospective Cohort Study[J]. Am J Gastroenterol, 2024, 119(6): 1158-1166.
[23]	Mederos M A, Reber H A, Girgis M D. Acute Pancreatitis: A Review[J]. JAMA, 2021, 325(4): 382-390.
[24]	Matta B, Gougol A, Gao X, et al. Worldwide Variations in Demographics, Management, and Outcomes of Acute Pancreatitis[J]. Clin Gastroenterol Hepatol, 2020, 18(7): 1567-1575 e1562.
[25]	Karim M M, Ur Rehman A, Majeed M A, et al. Pancreatic steatosis-a new modifiable high-risk factor for post-ERCP pancreatitis: yet much to explore[J]. Gastrointest Endosc, 2024, 100(3): 579-580.
[26]	KO J, Skudder-Hill L, Priya S, et al. Associations between Intra-Pancreatic Fat Deposition, Pancreas Size, and Pancreatic Enzymes in Health and after an Attack of Acute Pancreatitis[J]. Obes Facts, 2022, 15(1): 70-82.
[27]	Yan C, Bao J, Jin J. Exploring the interplay of gut microbiota, inflammation, and LDL-cholesterol: a multiomics Mendelian randomization analysis of their causal relationship in acute pancreatitis and non-alcoholic fatty liver disease[J]. J Transl Med, 2024, 22(1): 179.
[28]	Singh R G, Cervantes A, Kim J U, et al. Intrapancreatic fat deposition and visceral fat volume are associated with the presence of diabetes after acute pancreatitis[J]. Am J Physiol Gastrointest Liver Physiol, 2019, 316(6): G806-G815.
[29]	Stefanaki C, Paltoglou G, Mastorakos G, et al. Chronic Stress and Steatosis of Muscles, Bones, Liver, and Pancreas: A Review[J]. Horm Res Paediatr, 2023, 96(1): 66-73.
[30]	Adiamah A, Psaltis E, Crook M, et al. A systematic review of the epidemiology, pathophysiology and current management of hyperlipidaemic pancreatitis[J]. Clin Nutr, 2018, 37(6 Pt A): 1810-1822.
[31]	Pagkali A, Makris A, Brofidi K, et al. Pathophysiological Mechanisms and Clinical Associations of Non-Alcoholic Fatty Pancreas Disease[J]. Diabetes Metab Syndr Obes, 2024, 17: 283-294.
[32]	Navina S, Acharya C, Delany J P, et al. Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity[J]. Sci Transl Med, 2011, 3(107): 107ra110.
[33]	Durgampudi C, Noel P, Patel K, et al. Acute lipotoxicity regulates severity of biliary acute pancreatitis without affecting its initiation[J]. Am J Pathol, 2014, 184(6): 1773-1784.
[34]	Lilly A C, Astsaturov I, Golemis E A. Intrapancreatic fat, pancreatitis, and pancreatic cancer[J]. Cell Mol Life Sci, 2023, 80(8): 206.
[35]	Duarte-Rojo A, Sosa-Lozano L A, Saul A, et al. Methods for measuring abdominal obesity in the prediction of severe acute pancreatitis, and their correlation with abdominal fat areas assessed by computed tomography[J]. Aliment Pharmacol Ther, 2010, 32(2): 244-253.
[36]	Park J, Chang JH, Park SH, et al. Interleukin-6 is associated with obesity, central fat distribution, and disease severity in patients with acute pancreatitis[J]. Pancreatology, 2015, 15(1): 59-63.
[37]	Kuan LL, Dennison A R, Garcea G. Association of visceral adipose tissue on the incidence and severity of acute pancreatitis: A systematic review[J]. Pancreatology, 2020, 20(6): 1056-1061.
[38]	Patel K, Trivedi RN, Durgampudi C, et al. Lipolysis of visceral adipocyte triglyceride by pancreatic lipases converts mild acute pancreatitis to severe pancreatitis independent of necrosis and inflammation[J]. Am J Pathol, 2015, 185(3): 808-819.
[39]	Vancsa S, Nemeth D, Hegyi P, et al. Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease Worsen the Outcome in Acute Pancreatitis: A Systematic Review and Meta-Analysis[J]. J Clin Med, 2020, 9(9).
[40]	Mikolasevic I, Orlic L, Poropat G, et al. Nonalcoholic fatty liver and the severity of acute pancreatitis[J]. Eur J Intern Med, 2017, 38: 73-78.
[41]	Lin T Y, Zhang Y F, Wang Y, et al. Nonalcoholic fatty liver disease aggravates acute pancreatitis through bacterial translocation and cholesterol metabolic dysregulation in the liver and pancreas in mice[J]. Hepatobiliary Pancreat Dis Int, 2023, 22(5): 504-511.
[42]	Ren D, Li Y, Zhang G, et al. Lipid metabolic profiling and diagnostic model development for hyperlipidemic acute pancreatitis[J]. Front Physiol, 2024, 15: 1457349.
[43]	Otsuka N, Shimizu K, Taniai M, et al. Risk factors for fatty pancreas and effects of fatty infiltration on pancreatic cancer[J]. Front Physiol, 2023, 14: 1243983.
[44]	Truong E, Pandol S, Jeon C. Uniting epidemiology and experimental models: pancreatic steatosis and pancreatic cancer[J]. EBioMedicine, 2022, 79: 103996.
[45]	Chalasani N, Younossi Z, Lavine J E, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases[J]. Hepatology, 2018, 67(1): 328-357.
[46]	Petrov MS. The Pharmacological Landscape for Fatty Change of the Pancreas[J]. Drugs, 2024, 84(4): 375-384.
[47]	Jia DM, Fukumitsu KI, Tabaru A, et al. Troglitazone stimulates pancreatic growth in congenitally CCK-A receptor-deficient OLETF rats[J]. Am J Physiol Regul Integr Comp Physiol, 2001, 280(5): R1332-1340.
[48]	Souza-Mello V, Gregorio BM, Relvas-Lucas B, et al. Pancreatic ultrastructural enhancement due to telmisartan plus sitagliptin treatment in diet-induced obese C57BL/6 mice[J]. Pancreas, 2011, 40(5): 715-722.
[49]	Chen ZY, Liu SN, Li CN, et al. Atorvastatin helps preserve pancreatic beta cell function in obese C57BL/6 J mice and the effect is related to increased pancreas proliferation and amelioration of endoplasmic-reticulum stress[J]. Lipids Health Dis, 2014, 13: 98.
[50]	Sandoval DA, Patti ME. Glucose metabolism after bariatric surgery: implications for T2DM remission and hypoglycaemia[J]. Nat Rev Endocrinol, 2023, 19(3): 164-176.
[51]	Ji Y, Lee H, Kaura S, et al. Effect of Bariatric Surgery on Metabolic Diseases and Underlying Mechanisms[J]. Biomolecules, 2021, 11(11): 1582.
[52]	Hui Scn, Wong Skh, Ai Q, et al. Observed changes in brown, white, hepatic and pancreatic fat after bariatric surgery: Evaluation with MRI[J]. Eur Radiol, 2019, 29(2): 849-856.

Please choose a citation manager

Content to export